Point-of-care therapeutic drug monitoring of tumour necrosis factor-α inhibitors using a single step immunoassay
{{output}}
Therapeutic drug monitoring (TDM) of tumor necrosis factor-α (TNFα)-inhibitors adalimumab and infliximab is important to establish optimal drug dose and maximize treatment efficacy. Currently, TDM is primarily performed with ELISA techniques in clinical labo... ...
